0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Doxorubicin Hydrochloride Market Research Report 2026
Published Date: 2026-04-17
|
Report Code: QYRE-Auto-19B10707
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global and United States Doxorubicin Hydrochloride Market Report Forecast 2022 2028
BUY CHAPTERS

Global Doxorubicin Hydrochloride Market Research Report 2026

Code: QYRE-Auto-19B10707
Report
2026-04-17
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Doxorubicin Hydrochloride Market Size

The global Doxorubicin Hydrochloride market was valued at US$ 62.26 million in 2025 and is anticipated to reach US$ 97 million by 2032, at a CAGR of 6.6% from 2026 to 2032.

Doxorubicin Hydrochloride Market

Doxorubicin Hydrochloride Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Doxorubicin Hydrochloride competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Doxorubicin hydrochloride is a type of chemotherapy drug called an anthracycline. It blocks an enzyme called topoisomerase II, which cuts and repairs tangled strands of DNA. This stops or slows the growth of cancer cells and other rapidly dividing cells.1
The global core manufacturers of Doxorubicin Hydrochloride include Pfizer, Teva and Viatris. The top three companies have a market share of about 50%. Asia Pacific is the world's largest market for Doxorubicin Hydrochloride with a market share of about 39%, followed by North America and Europe with a market share of 30% and 27%, respectively. In terms of product type, 10mg is the largest segment with approximately 32% market share. In terms of application, Lung Cancer is the largest downstream segment, accounting for about 24% of the market.
This report delivers a comprehensive overview of the global Doxorubicin Hydrochloride market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Doxorubicin Hydrochloride. The Doxorubicin Hydrochloride market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Doxorubicin Hydrochloride market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Doxorubicin Hydrochloride manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Doxorubicin Hydrochloride Market Report

Report Metric Details
Report Name Doxorubicin Hydrochloride Market
Accounted market size in 2025 US$ 62.26 in million
Forecasted market size in 2032 US$ 97 million
CAGR 6.6%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • 10mg
  • 20mg
  • 50mg
  • 200mg
  • Others
by Application
  • Breast Cancer
  • Acute Leukemia
  • Lung Cancer
  • Malignant Lymphoma
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Teva, Viatris, Medac GmbH, Fresenius Kabi, Sun Pharmaceutical, Shanxi PUDE Pharmaceutical, Zhejiang Hisun (HanHui Pharmaceuticals), Shenzhen Main Luck Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Doxorubicin Hydrochloride manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Doxorubicin Hydrochloride sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Doxorubicin Hydrochloride Market growing?

Ans: The Doxorubicin Hydrochloride Market witnessing a CAGR of 6.6% during the forecast period 2026-2032.

What is the Doxorubicin Hydrochloride Market size in 2032?

Ans: The Doxorubicin Hydrochloride Market size in 2032 will be US$ 97 million.

What is the market share of major companies in Doxorubicin Hydrochloride Market?

Ans: The top three companies have a market share of about 50%.

What is the Doxorubicin Hydrochloride Market share by region?

Ans: Asia Pacific is the world's largest market for Doxorubicin Hydrochloride with a market share of about 39%, followed by North America and Europe with a market share of 30% and 27%, respectively.

What is the Doxorubicin Hydrochloride Market share by type?

Ans: In terms of product type, 10mg is the largest segment with approximately 32% market share.

What is the Doxorubicin Hydrochloride Market share by application?

Ans: In terms of application, Lung Cancer is the largest downstream segment, accounting for about 24% of the market.

Who are the main players in the Doxorubicin Hydrochloride Market report?

Ans: The main players in the Doxorubicin Hydrochloride Market are Pfizer, Teva, Viatris, Medac GmbH, Fresenius Kabi, Sun Pharmaceutical, Shanxi PUDE Pharmaceutical, Zhejiang Hisun (HanHui Pharmaceuticals), Shenzhen Main Luck Pharmaceuticals

What are the Application segmentation covered in the Doxorubicin Hydrochloride Market report?

Ans: The Applications covered in the Doxorubicin Hydrochloride Market report are Breast Cancer, Acute Leukemia, Lung Cancer, Malignant Lymphoma, Others

What are the Type segmentation covered in the Doxorubicin Hydrochloride Market report?

Ans: The Types covered in the Doxorubicin Hydrochloride Market report are 10mg, 20mg, 50mg, 200mg, Others

1 Doxorubicin Hydrochloride Market Overview
1.1 Product Definition
1.2 Doxorubicin Hydrochloride by Type
1.2.1 Global Doxorubicin Hydrochloride Market Value by Type: 2025 vs 2032
1.2.2 10mg
1.2.3 20mg
1.2.4 50mg
1.2.5 200mg
1.2.6 Others
1.3 Doxorubicin Hydrochloride by Application
1.3.1 Global Doxorubicin Hydrochloride Market Value by Application: 2025 vs 2032
1.3.2 Breast Cancer
1.3.3 Acute Leukemia
1.3.4 Lung Cancer
1.3.5 Malignant Lymphoma
1.3.6 Others
1.4 Global Doxorubicin Hydrochloride Market Size Estimates and Forecasts
1.4.1 Global Doxorubicin Hydrochloride Revenue 2021–2032
1.4.2 Global Doxorubicin Hydrochloride Sales 2021–2032
1.4.3 Global Doxorubicin Hydrochloride Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Doxorubicin Hydrochloride Market Competition by Manufacturers
2.1 Global Doxorubicin Hydrochloride Sales Market Share by Manufacturers (2021–2026)
2.2 Global Doxorubicin Hydrochloride Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Doxorubicin Hydrochloride Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Doxorubicin Hydrochloride, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Doxorubicin Hydrochloride, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Doxorubicin Hydrochloride, Product Types and Applications
2.7 Global Key Manufacturers of Doxorubicin Hydrochloride, Date of Entry into the Industry
2.8 Global Doxorubicin Hydrochloride Market Competitive Situation and Trends
2.8.1 Global Doxorubicin Hydrochloride Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Doxorubicin Hydrochloride Players Market Share by Revenue
2.8.3 Global Doxorubicin Hydrochloride Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Doxorubicin Hydrochloride Market Scenario by Region
3.1 Global Doxorubicin Hydrochloride Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Doxorubicin Hydrochloride Sales by Region: 2021–2032
3.2.1 Global Doxorubicin Hydrochloride Sales by Region: 2021–2026
3.2.2 Global Doxorubicin Hydrochloride Sales by Region: 2027–2032
3.3 Global Doxorubicin Hydrochloride Revenue by Region: 2021–2032
3.3.1 Global Doxorubicin Hydrochloride Revenue by Region: 2021–2026
3.3.2 Global Doxorubicin Hydrochloride Revenue by Region: 2027–2032
3.4 North America Doxorubicin Hydrochloride Market Facts & Figures by Country
3.4.1 North America Doxorubicin Hydrochloride Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Doxorubicin Hydrochloride Sales by Country (2021–2032)
3.4.3 North America Doxorubicin Hydrochloride Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Doxorubicin Hydrochloride Market Facts & Figures by Country
3.5.1 Europe Doxorubicin Hydrochloride Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Doxorubicin Hydrochloride Sales by Country (2021–2032)
3.5.3 Europe Doxorubicin Hydrochloride Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Doxorubicin Hydrochloride Market Facts & Figures by Region
3.6.1 Asia Pacific Doxorubicin Hydrochloride Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Doxorubicin Hydrochloride Sales by Region (2021–2032)
3.6.3 Asia Pacific Doxorubicin Hydrochloride Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.7 Latin America Doxorubicin Hydrochloride Market Facts & Figures by Country
3.7.1 Latin America Doxorubicin Hydrochloride Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Doxorubicin Hydrochloride Sales by Country (2021–2032)
3.7.3 Latin America Doxorubicin Hydrochloride Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Doxorubicin Hydrochloride Market Facts & Figures by Country
3.8.1 Middle East and Africa Doxorubicin Hydrochloride Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Doxorubicin Hydrochloride Sales by Country (2021–2032)
3.8.3 Middle East and Africa Doxorubicin Hydrochloride Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Doxorubicin Hydrochloride Sales by Type (2021–2032)
4.1.1 Global Doxorubicin Hydrochloride Sales by Type (2021–2026)
4.1.2 Global Doxorubicin Hydrochloride Sales by Type (2027–2032)
4.1.3 Global Doxorubicin Hydrochloride Sales Market Share by Type (2021–2032)
4.2 Global Doxorubicin Hydrochloride Revenue by Type (2021–2032)
4.2.1 Global Doxorubicin Hydrochloride Revenue by Type (2021–2026)
4.2.2 Global Doxorubicin Hydrochloride Revenue by Type (2027–2032)
4.2.3 Global Doxorubicin Hydrochloride Revenue Market Share by Type (2021–2032)
4.3 Global Doxorubicin Hydrochloride Price by Type (2021–2032)
5 Segment by Application
5.1 Global Doxorubicin Hydrochloride Sales by Application (2021–2032)
5.1.1 Global Doxorubicin Hydrochloride Sales by Application (2021–2026)
5.1.2 Global Doxorubicin Hydrochloride Sales by Application (2027–2032)
5.1.3 Global Doxorubicin Hydrochloride Sales Market Share by Application (2021–2032)
5.2 Global Doxorubicin Hydrochloride Revenue by Application (2021–2032)
5.2.1 Global Doxorubicin Hydrochloride Revenue by Application (2021–2026)
5.2.2 Global Doxorubicin Hydrochloride Revenue by Application (2027–2032)
5.2.3 Global Doxorubicin Hydrochloride Revenue Market Share by Application (2021–2032)
5.3 Global Doxorubicin Hydrochloride Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Doxorubicin Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Pfizer Doxorubicin Hydrochloride Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Teva
6.2.1 Teva Company Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Doxorubicin Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Teva Doxorubicin Hydrochloride Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Viatris
6.3.1 Viatris Company Information
6.3.2 Viatris Description and Business Overview
6.3.3 Viatris Doxorubicin Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Viatris Doxorubicin Hydrochloride Product Portfolio
6.3.5 Viatris Recent Developments/Updates
6.4 Medac GmbH
6.4.1 Medac GmbH Company Information
6.4.2 Medac GmbH Description and Business Overview
6.4.3 Medac GmbH Doxorubicin Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Medac GmbH Doxorubicin Hydrochloride Product Portfolio
6.4.5 Medac GmbH Recent Developments/Updates
6.5 Fresenius Kabi
6.5.1 Fresenius Kabi Company Information
6.5.2 Fresenius Kabi Description and Business Overview
6.5.3 Fresenius Kabi Doxorubicin Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Fresenius Kabi Doxorubicin Hydrochloride Product Portfolio
6.5.5 Fresenius Kabi Recent Developments/Updates
6.6 Sun Pharmaceutical
6.6.1 Sun Pharmaceutical Company Information
6.6.2 Sun Pharmaceutical Description and Business Overview
6.6.3 Sun Pharmaceutical Doxorubicin Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Sun Pharmaceutical Doxorubicin Hydrochloride Product Portfolio
6.6.5 Sun Pharmaceutical Recent Developments/Updates
6.7 Shanxi PUDE Pharmaceutical
6.7.1 Shanxi PUDE Pharmaceutical Company Information
6.7.2 Shanxi PUDE Pharmaceutical Description and Business Overview
6.7.3 Shanxi PUDE Pharmaceutical Doxorubicin Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Shanxi PUDE Pharmaceutical Doxorubicin Hydrochloride Product Portfolio
6.7.5 Shanxi PUDE Pharmaceutical Recent Developments/Updates
6.8 Zhejiang Hisun (HanHui Pharmaceuticals)
6.8.1 Zhejiang Hisun (HanHui Pharmaceuticals) Company Information
6.8.2 Zhejiang Hisun (HanHui Pharmaceuticals) Description and Business Overview
6.8.3 Zhejiang Hisun (HanHui Pharmaceuticals) Doxorubicin Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Zhejiang Hisun (HanHui Pharmaceuticals) Doxorubicin Hydrochloride Product Portfolio
6.8.5 Zhejiang Hisun (HanHui Pharmaceuticals) Recent Developments/Updates
6.9 Shenzhen Main Luck Pharmaceuticals
6.9.1 Shenzhen Main Luck Pharmaceuticals Company Information
6.9.2 Shenzhen Main Luck Pharmaceuticals Description and Business Overview
6.9.3 Shenzhen Main Luck Pharmaceuticals Doxorubicin Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Shenzhen Main Luck Pharmaceuticals Doxorubicin Hydrochloride Product Portfolio
6.9.5 Shenzhen Main Luck Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Doxorubicin Hydrochloride Industry Chain Analysis
7.2 Doxorubicin Hydrochloride Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Doxorubicin Hydrochloride Production Mode & Process Analysis
7.4 Doxorubicin Hydrochloride Sales and Marketing
7.4.1 Doxorubicin Hydrochloride Sales Channels
7.4.2 Doxorubicin Hydrochloride Distributors
7.5 Doxorubicin Hydrochloride Customer Analysis
8 Doxorubicin Hydrochloride Market Dynamics
8.1 Doxorubicin Hydrochloride Industry Trends
8.2 Doxorubicin Hydrochloride Market Drivers
8.3 Doxorubicin Hydrochloride Market Challenges
8.4 Doxorubicin Hydrochloride Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Doxorubicin Hydrochloride Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Doxorubicin Hydrochloride Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Doxorubicin Hydrochloride Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Doxorubicin Hydrochloride Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Doxorubicin Hydrochloride Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Doxorubicin Hydrochloride Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Doxorubicin Hydrochloride Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Doxorubicin Hydrochloride Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Doxorubicin Hydrochloride, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Doxorubicin Hydrochloride, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Doxorubicin Hydrochloride, Product Types and Applications
 Table 12. Global Key Manufacturers of Doxorubicin Hydrochloride, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Doxorubicin Hydrochloride Companies by Tier (Tier 1, Tier 2, Tier 3), based on Doxorubicin Hydrochloride Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Doxorubicin Hydrochloride Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Doxorubicin Hydrochloride Sales by Region (K Units), 2021–2026
 Table 18. Global Doxorubicin Hydrochloride Sales Market Share by Region (2021–2026)
 Table 19. Global Doxorubicin Hydrochloride Sales by Region (K Units), 2027–2032
 Table 20. Global Doxorubicin Hydrochloride Sales Market Share by Region (2027–2032)
 Table 21. Global Doxorubicin Hydrochloride Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Doxorubicin Hydrochloride Revenue Market Share by Region (2021–2026)
 Table 23. Global Doxorubicin Hydrochloride Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Doxorubicin Hydrochloride Revenue Market Share by Region (2027–2032)
 Table 25. North America Doxorubicin Hydrochloride Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Doxorubicin Hydrochloride Sales by Country (K Units), 2021–2026
 Table 27. North America Doxorubicin Hydrochloride Sales by Country (K Units), 2027–2032
 Table 28. North America Doxorubicin Hydrochloride Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Doxorubicin Hydrochloride Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Doxorubicin Hydrochloride Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Doxorubicin Hydrochloride Sales by Country (K Units), 2021–2026
 Table 32. Europe Doxorubicin Hydrochloride Sales by Country (K Units), 2027–2032
 Table 33. Europe Doxorubicin Hydrochloride Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Doxorubicin Hydrochloride Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Doxorubicin Hydrochloride Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Doxorubicin Hydrochloride Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Doxorubicin Hydrochloride Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Doxorubicin Hydrochloride Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Doxorubicin Hydrochloride Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Doxorubicin Hydrochloride Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Doxorubicin Hydrochloride Sales by Country (K Units), 2021–2026
 Table 42. Latin America Doxorubicin Hydrochloride Sales by Country (K Units), 2027–2032
 Table 43. Latin America Doxorubicin Hydrochloride Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Doxorubicin Hydrochloride Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Doxorubicin Hydrochloride Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Doxorubicin Hydrochloride Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Doxorubicin Hydrochloride Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Doxorubicin Hydrochloride Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Doxorubicin Hydrochloride Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Doxorubicin Hydrochloride Sales (K Units) by Type (2021–2026)
 Table 51. Global Doxorubicin Hydrochloride Sales (K Units) by Type (2027–2032)
 Table 52. Global Doxorubicin Hydrochloride Sales Market Share by Type (2021–2026)
 Table 53. Global Doxorubicin Hydrochloride Sales Market Share by Type (2027–2032)
 Table 54. Global Doxorubicin Hydrochloride Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Doxorubicin Hydrochloride Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Doxorubicin Hydrochloride Revenue Market Share by Type (2021–2026)
 Table 57. Global Doxorubicin Hydrochloride Revenue Market Share by Type (2027–2032)
 Table 58. Global Doxorubicin Hydrochloride Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Doxorubicin Hydrochloride Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Doxorubicin Hydrochloride Sales (K Units) by Application (2021–2026)
 Table 61. Global Doxorubicin Hydrochloride Sales (K Units) by Application (2027–2032)
 Table 62. Global Doxorubicin Hydrochloride Sales Market Share by Application (2021–2026)
 Table 63. Global Doxorubicin Hydrochloride Sales Market Share by Application (2027–2032)
 Table 64. Global Doxorubicin Hydrochloride Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Doxorubicin Hydrochloride Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Doxorubicin Hydrochloride Revenue Market Share by Application (2021–2026)
 Table 67. Global Doxorubicin Hydrochloride Revenue Market Share by Application (2027–2032)
 Table 68. Global Doxorubicin Hydrochloride Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Doxorubicin Hydrochloride Price (US$/Unit) by Application (2027–2032)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Doxorubicin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Pfizer Doxorubicin Hydrochloride Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Teva Company Information
 Table 76. Teva Description and Business Overview
 Table 77. Teva Doxorubicin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Teva Doxorubicin Hydrochloride Product
 Table 79. Teva Recent Developments/Updates
 Table 80. Viatris Company Information
 Table 81. Viatris Description and Business Overview
 Table 82. Viatris Doxorubicin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Viatris Doxorubicin Hydrochloride Product
 Table 84. Viatris Recent Developments/Updates
 Table 85. Medac GmbH Company Information
 Table 86. Medac GmbH Description and Business Overview
 Table 87. Medac GmbH Doxorubicin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Medac GmbH Doxorubicin Hydrochloride Product
 Table 89. Medac GmbH Recent Developments/Updates
 Table 90. Fresenius Kabi Company Information
 Table 91. Fresenius Kabi Description and Business Overview
 Table 92. Fresenius Kabi Doxorubicin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Fresenius Kabi Doxorubicin Hydrochloride Product
 Table 94. Fresenius Kabi Recent Developments/Updates
 Table 95. Sun Pharmaceutical Company Information
 Table 96. Sun Pharmaceutical Description and Business Overview
 Table 97. Sun Pharmaceutical Doxorubicin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Sun Pharmaceutical Doxorubicin Hydrochloride Product
 Table 99. Sun Pharmaceutical Recent Developments/Updates
 Table 100. Shanxi PUDE Pharmaceutical Company Information
 Table 101. Shanxi PUDE Pharmaceutical Description and Business Overview
 Table 102. Shanxi PUDE Pharmaceutical Doxorubicin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Shanxi PUDE Pharmaceutical Doxorubicin Hydrochloride Product
 Table 104. Shanxi PUDE Pharmaceutical Recent Developments/Updates
 Table 105. Zhejiang Hisun (HanHui Pharmaceuticals) Company Information
 Table 106. Zhejiang Hisun (HanHui Pharmaceuticals) Description and Business Overview
 Table 107. Zhejiang Hisun (HanHui Pharmaceuticals) Doxorubicin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Zhejiang Hisun (HanHui Pharmaceuticals) Doxorubicin Hydrochloride Product
 Table 109. Zhejiang Hisun (HanHui Pharmaceuticals) Recent Developments/Updates
 Table 110. Shenzhen Main Luck Pharmaceuticals Company Information
 Table 111. Shenzhen Main Luck Pharmaceuticals Description and Business Overview
 Table 112. Shenzhen Main Luck Pharmaceuticals Doxorubicin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Shenzhen Main Luck Pharmaceuticals Doxorubicin Hydrochloride Product
 Table 114. Shenzhen Main Luck Pharmaceuticals Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Doxorubicin Hydrochloride Distributors List
 Table 118. Doxorubicin Hydrochloride Customers List
 Table 119. Doxorubicin Hydrochloride Market Trends
 Table 120. Doxorubicin Hydrochloride Market Drivers
 Table 121. Doxorubicin Hydrochloride Market Challenges
 Table 122. Doxorubicin Hydrochloride Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Doxorubicin Hydrochloride
 Figure 2. Global Doxorubicin Hydrochloride Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Doxorubicin Hydrochloride Market Share by Type: 2025 & 2032
 Figure 4. 10mg Product Picture
 Figure 5. 20mg Product Picture
 Figure 6. 50mg Product Picture
 Figure 7. 200mg Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Doxorubicin Hydrochloride Market Value by Application (US$ Million), 2021–2032
 Figure 10. Global Doxorubicin Hydrochloride Market Share by Application: 2025 & 2032
 Figure 11. Breast Cancer
 Figure 12. Acute Leukemia
 Figure 13. Lung Cancer
 Figure 14. Malignant Lymphoma
 Figure 15. Others
 Figure 16. Global Doxorubicin Hydrochloride Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 17. Global Doxorubicin Hydrochloride Market Size (US$ Million), 2021–2032
 Figure 18. Global Doxorubicin Hydrochloride Sales (K Units), 2021–2032
 Figure 19. Global Doxorubicin Hydrochloride Average Price (US$/Unit), 2021–2032
 Figure 20. Doxorubicin Hydrochloride Report Years Considered
 Figure 21. Doxorubicin Hydrochloride Sales Share by Manufacturers in 2025
 Figure 22. Global Doxorubicin Hydrochloride Revenue Share by Manufacturers in 2025
 Figure 23. Top 5 and Top 10 Global Doxorubicin Hydrochloride Players: Market Share by Revenue in Doxorubicin Hydrochloride in 2025
 Figure 24. Doxorubicin Hydrochloride Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 25. Global Doxorubicin Hydrochloride Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 26. North America Doxorubicin Hydrochloride Sales Market Share by Country (2021–2032)
 Figure 27. North America Doxorubicin Hydrochloride Revenue Market Share by Country (2021–2032)
 Figure 28. U.S. Doxorubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Canada Doxorubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Europe Doxorubicin Hydrochloride Sales Market Share by Country (2021–2032)
 Figure 31. Europe Doxorubicin Hydrochloride Revenue Market Share by Country (2021–2032)
 Figure 32. Germany Doxorubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. France Doxorubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. U.K. Doxorubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Italy Doxorubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Russia Doxorubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Asia Pacific Doxorubicin Hydrochloride Sales Market Share by Region (2021–2032)
 Figure 38. Asia Pacific Doxorubicin Hydrochloride Revenue Market Share by Region (2021–2032)
 Figure 39. China Doxorubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Japan Doxorubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. South Korea Doxorubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. India Doxorubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Australia Doxorubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Doxorubicin Hydrochloride Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Doxorubicin Hydrochloride Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Doxorubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Doxorubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Doxorubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Doxorubicin Hydrochloride Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Doxorubicin Hydrochloride Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Doxorubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Doxorubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. U.A.E Doxorubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Doxorubicin Hydrochloride by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Doxorubicin Hydrochloride by Type (2021–2032)
 Figure 56. Global Doxorubicin Hydrochloride Price (US$/Unit) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Doxorubicin Hydrochloride by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Doxorubicin Hydrochloride by Application (2021–2032)
 Figure 59. Global Doxorubicin Hydrochloride Price (US$/Unit) by Application (2021–2032)
 Figure 60. Doxorubicin Hydrochloride Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools